-
Mashup Score: 0RSV, COVID-19, and Flu Outlook for 2023-2024 | Johns Hopkins Bloomberg School of Public Health - 2 year(s) ago
Last year’s “tripledemic” of COVID, RSV, and flu may raise concerns about the upcoming virus season, but an infectious disease epidemiologist sees reasons for optimism.
Source: publichealth.jhu.eduCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 21Four Bloomberg School Faculty Elected to National Academy of Medicine | Johns Hopkins Bloomberg School of Public Health - 2 year(s) ago
Considered one of the highest honors in the fields of health and medicine, NAM membership recognizes outstanding professional achievements and commitment to service.
Source: publichealth.jhu.eduCategories: General Medicine News, Latest HeadlinesTweet-
NEWS: Four @JohnsHopkinsSPH professors have been elected to @theNAMedicine, along with three colleagues from @HopkinsMedicine. The Bloomberg School’s NAM Class of 2023: • @DR_KMP • @T_Inglesby • @DanielWWebster1 • @BandeenKaren https://t.co/Gx4Y6RuWCP
-
-
Mashup Score: 6Vaccine Trials Can Be More Inclusive of Older Adults | Johns Hopkins Bloomberg School of Public Health - 2 year(s) ago
Adults over age 75 are routinely excluded from clinical trials in the name of safety and efficiency—but leaving them out also creates uncertainty about how well products actually work for them.
Source: publichealth.jhu.eduCategories: General Medicine News, Latest HeadlinesTweet-
"Ultimately, we want to get the vaccines tested and rolled out to vulnerable populations as early as possible, instead of having them be an afterthought in the clinical trial process." https://t.co/MFOiX7xoyp
-
-
Mashup Score: 3Vaccine Trials Can Be More Inclusive of Older Adults | Johns Hopkins Bloomberg School of Public Health - 2 year(s) ago
Adults over age 75 are routinely excluded from clinical trials in the name of safety and efficiency—but leaving them out also creates uncertainty about how well products actually work for them.
Source: publichealth.jhu.eduCategories: General Medicine News, Latest HeadlinesTweet-
"A vaccine that is effective in a healthy adult under 60 isn’t necessarily going to work as well in someone in their 80s or 90s. So when a vaccine enters larger efficacy trials, that's when it's really important to start adding older adults..." https://t.co/MFOiX7xoyp
-
-
Mashup Score: 5
Scientists identify protein and pathway that, if compromised, no longer protect Aedes aegypti mosquitoes from succumbing to viruses they transmit to people.
Source: publichealth.jhu.eduCategories: General Medicine News, Latest HeadlinesTweet-
Researchers with @JHMRImalaria found that in Ae. aegypti mosquitoes lacking the Ago2 gene, the siRNA pathway is impaired, arborvirus infection becomes more severe, and the mosquitoes’ ability to transmit these viruses drops sharply. https://t.co/UgVOw5xwr7
-
-
Mashup Score: 5
We spend most of our lives indoors, so how can we ensure the air we breathe there is as safe as possible? A new model law could help.
Source: publichealth.jhu.eduCategories: General Medicine News, Latest HeadlinesTweet-
“It's not something we should be ignoring,” says @GGronvall. “If you breathe poor air, you're not going to do as well, you're not going to think as well.” https://t.co/nRnq56DHzt
-
-
Mashup Score: 11
A look at how this vaccine technology has been in the works for decades.
Source: publichealth.jhu.eduCategories: General Medicine News, Latest HeadlinesTweet-
Messenger RNA, or mRNA, was discovered in the early 1960s; research into how mRNA could be delivered into cells was developed in the 1970s. So, why did it take until the global COVID-19 pandemic of 2020 for the first mRNA vaccine to be brought to market? https://t.co/SyVl4Hfj9j
-
-
Mashup Score: 6What to Know About the Updated COVID-19 Vaccine for Fall/Winter 2023 | Johns Hopkins Bloomberg School of Public Health - 2 year(s) ago
The updated COVID-19 vaccine provides safe, effective protection against current variants for everyone six months and older.
Source: publichealth.jhu.eduCategories: General Medicine News, Latest HeadlinesTweet-
"Overall, studies show that the updated vaccine is effective against the variants currently causing the majority of COVID cases in the U.S.: EG.5, FL.1.5.1, and others in the XBB family." https://t.co/tCEC1l6i2Z
-
-
Mashup Score: 4What to Know About the Updated COVID-19 Vaccine for Fall/Winter 2023 | Johns Hopkins Bloomberg School of Public Health - 2 year(s) ago
The updated COVID-19 vaccine provides safe, effective protection against current variants for everyone six months and older.
Source: publichealth.jhu.eduCategories: General Medicine News, Latest HeadlinesTweet-
A team led by researchers at @JohnsHopkinsSPH and @theNCI has developed a new algorithm for genetic risk-scoring for major diseases across diverse ancestry populations that holds promise for reducing health care disparities. https://t.co/tCEC1l6i2Z
-
-
Mashup Score: 3
Methadone is proven to reduce the likelihood of dying from an overdose by 50% or more. Why is it so hard to get?
Source: publichealth.jhu.eduCategories: General Medicine News, Latest HeadlinesTweet-
"The regulations [on methadone] are 50 years old, and they've never been changed." https://t.co/9KJc8MaUUi
-
Don't forget to get your season flu shot, either, and please stay up to date on your COVID vaccines. Read more from @JohnsHopkinsSPH: https://t.co/ggPyLb681H https://t.co/cdZntKib3j